Form Type: 4

SEC EDGAR Link
Acccession Number:0001104659-20-002087
Date:2020-01-03
Issuer: IOVANCE BIOTHERAPEUTICS, INC. (IOVA)
Original Submission Date:

Reporting Person:

GRAF FINCKENSTEIN FRIEDRICH
C/O IOVANCE BIOTHERAPEUTICS, INC.
999 SKYWAY ROAD, SUITE 150 SAN CARLOS, CA 94070

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 25.54 2020-01-03 deemed execution date A 75,000 (a) 2030-01-02 common stock 75,000 $25.54 75,000 direct
Footnotes
IDfootnote
f1 provided the reporting person is still employed with the issuer on the following dates, the options are exercisable as follows: (i) options for the purchase of one-third of the 75,000 shares shall vest on the one-year anniversary of january 3, 2020; and (ii) the remaining options shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of january 3, 2020.

Elevate your investments